One other potentially great thing Imugene are doing with this trial is testing Her-vaxx as a kind of vaccine. Once the tumor is surgically removed, the her-vaxx is then used to prevent it recurring. That's a potentially amazing (long) road to head down, cancer vaccines.
Best of luck to the patients and all.
Ann: Clinical Trial Supply Agreement with Merck KGaA and Pfizer, page-154
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.035(10.3%) |
Mkt cap ! $90.22M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 35.0¢ | 30.5¢ | $3.123M | 9.967M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 648154 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 1371967 | 2 |
View Market Depth
| Last trade - 16.18pm 19/09/2025 (20 minute delay) ? |
| IMU (ASX) Chart |